In contrast, when an inhibitor of thioredoxin reductase (TrxR) activity (Auranofin; Au, 1 μM), was combined with 2DG+DHEA or DHEA-alone for 24 h, clonogenic cell killing was significantly increased in all three human cancer cell lines. Here, PRDX5 is linked to cancer.